Acknowledgements
René, Hôpitaux du Léman, COJOCARASU, cancer Avignon-Provence
MORVAN
We thank the patients, who participated in the trial, and their families. We acknowledge Bénédicte VOTAN, Sébastien ARMANET, Aurélie CHABANON, Sarah SUARD and Amina HAMEK from the GINECO study office. We also thank the following investigators who participated in the trial: Rania BOUSTANY GRENIER, Gaëtan DE RAUGLAUDRE, Yvelise GOUBELY, Julien GRENIER and Alice MEGE (Institut du cancer Avignon-Provence, Avignon), Dominique BERTON, Emmanuelle BOURBOULOUX and Jean-Sébastien FRENEL (Institut de Cancérologie de l’Ouest, Centre René Gauducheau, Saint Herblain), Olivia BALLY, Isabelle RAY-COQUARD, Catherine TERRET and Olivier TREDAN (Centre Léon Bérard, Lyon), Nathalie BONNIN, Claire FALANDRY and Sophie TARTAS (Centre Hospitalier Lyon Sud, Pierre Benite), Stéphane LOPEZ and Oana POP (Centre Hospitalier Annecy Genevois, Pringy), Laurence LANCRY-LECOMTE and Cécile LEYRONNAS (Groupe Hospitalier Mutualiste de Grenoble, Grenoble), Laura DEIANA (Hôpital Morvan, CHU de Brest, Brest), Olfa DERBEL MILED (Hôpital Privé Jean Mermoz, Lyon), Khoutir MAHOUR-BACHA (Hôpitaux du Léman, Thonon-les-Bains), Tifenn L'HARIDON (Centre Hospitalier Départemental Vendée Les Oudairies, La Roche Sur Yon), Dominique SPAETH (ORACLE—Centre d'Oncologie de Gentilly, Gentilly), Oana COJOCARASU (Centre Hospitalier du Mans, Le Mans), and all pharmacists and members of the site study team, as well as Pierre Fabre for their financial support.